TP53 and cancer: However, a good fraction of tumors do not present with LOH for TP53, indicating that mutations of the gene might not be necessarily the primary driver of oncogenesis, but might occur at later stages and be just one among many critical pathological events that accumulate during a cancer cell’s life.